LEAWOOD, Kan., Nov. 28, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats, today announced that it has terminated the offering of shares of its common stock that was announced on Monday, November 27, 2017. The company believes that current market conditions are not conducive for an offering on terms that would be in the best interests of its stockholders.
Contacts
For investor inquires:
Craig Tooman
[email protected]
(913) 353-1026
For media inquiries:
Rachel Reiff
[email protected]
(913) 353-1050
SOURCE Aratana Therapeutics, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
Newsrooms &
Influencers
9k+
Digital Media
Outlets
Digital Media
Outlets
270k+
Journalists
Opted In
Journalists
Opted In
Share this article